Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,140 | 21,287 | 9,828 | 15,158 | 42,666 |
| Marketable Securities | 34,167 | 39,811 | 47,829 | 50,674 | 32,700 |
| Receivables | 243 | 324 | 456 | 738 | 859 |
| TOTAL | $46,228 | $62,947 | $59,200 | $68,251 | $78,283 |
| Non-Current Assets | |||||
| PPE Net | 10,472 | 10,832 | 10,924 | 10,972 | 10,965 |
| Intangibles | 35,318 | 35,801 | 36,284 | 36,766 | 37,424 |
| Other Non-Current Assets | 386 | 363 | 5,401 | 5,582 | 5,773 |
| TOTAL | $46,176 | $46,996 | $52,609 | $53,320 | $54,162 |
| Total Assets | $92,404 | $109,943 | $111,809 | $121,571 | $132,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,982 | 13,523 | 13,306 | 12,048 | 11,866 |
| Accounts payable and accrued liabilities | 738 | 931 | 741 | 1,073 | 1,617 |
| Accrued Expenses | 4,200 | 4,936 | 4,178 | 4,134 | 3,810 |
| Other current liabilities | N/A | 818 | N/A | 1,174 | 2,387 |
| TOTAL | $8,920 | $20,208 | $23,281 | $23,714 | $24,824 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,697 | 8,889 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 5,056 | 5,285 | 5,144 |
| Other Non-Current Liabilities | 6,002 | 5,591 | 5,587 | 5,798 | 6,024 |
| TOTAL | $17,699 | $14,480 | $36,507 | $37,855 | $39,162 |
| Total Liabilities | $26,619 | $34,688 | $59,788 | $61,569 | $63,986 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,171 | 2,138 | 2,138 | 2,127 | 2,120 |
| Common Shares | 32 | 32 | 32 | 32 | 32 |
| Retained earnings | -170,266 | -160,207 | -182,868 | -173,781 | -164,256 |
| Other shareholders' equity | 2,760 | 2,751 | 2,796 | 2,658 | 2,663 |
| TOTAL | $65,785 | $75,255 | $52,021 | $60,002 | $68,459 |
| Total Liabilities And Equity | $92,404 | $109,943 | $111,809 | $121,571 | $132,445 |